Author: Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.
Finance

Active STocks at NYSE; AT&T Inc. (NYSE:T), Petroleo Brasileiro Petrobras) (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

U.S. telecom giant AT&T Inc. (NYSE:T) has announced a new repurchase program of up to 300 million shares. The buyback represents nearly 6% of the company’s outstanding shares and does not have any expiration date. AT&T Inc. (NYSE:T) stock performance was 0.06% in last session and finished the day at $35.09. Traded volume was 28.78million shares in the last session and the average volume of … Continue reading Active STocks at NYSE; AT&T Inc. (NYSE:T), Petroleo Brasileiro Petrobras) (NYSE:PBR), Pfizer Inc. (NYSE:PFE)

Mark DeFrance
Finance

Regional Midwest Banks: Huntington Bancshares Incorporated (NASDAQ:HBAN), KeyCorp (NYSE:KEY), U.S. Bancorp (NYSE:USB), First Financial Bancorp (NASDAQ:FFBC)

Shares of Huntington Bancshares (NASDAQ:HBAN) saw a large decline in short interest in January. As of March 14th, there was short interest totalling 15,966,545 shares, a decline of 12.8% from the February 28th total of 18,306,242 shares, AR Network reports. Huntington Bancshares Incorporated (NASDAQ:HBAN) stock performance was 1.91% in last session and finished the day at $10.16. Traded volume was 11,499,600 million shares in the … Continue reading Regional Midwest Banks: Huntington Bancshares Incorporated (NASDAQ:HBAN), KeyCorp (NYSE:KEY), U.S. Bancorp (NYSE:USB), First Financial Bancorp (NASDAQ:FFBC)

Mark DeFrance
Finance

Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational treatment. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 6.15% in … Continue reading Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Mark DeFrance
FB Nasdaq FB Facebook
Finance

Utilities Most Active Stocks: FuelCell Energy (NASDAQ:FCEL), Exelon Corporation (NYSE:EXC), PG&E Corporation (NYSE:PCG), AES Corp (NYSE:AES)

Trade-Ideas LLC identified FuelCell Energy Inc (NASDAQ:FCEL) as a “dead cat bounce” (down big yesterday but up big today) candidate. TheStreet Quant Ratings rates FuelCell Energy Inc (NASDAQ:FCEL) as a sell. FuelCell Energy Inc (NASDAQ:FCEL) stock performance was 8.30% in last session and finished the day at $2.48. Traded volume was 21.81million shares in the last session and the average volume of the stock remained … Continue reading Utilities Most Active Stocks: FuelCell Energy (NASDAQ:FCEL), Exelon Corporation (NYSE:EXC), PG&E Corporation (NYSE:PCG), AES Corp (NYSE:AES)

Mark DeFrance
Finance

Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)

Gilead Sciences, Inc. (NASDAQ:GILD) was active yesterday as one Bloomberg reporter thinks he has another take on the recent Waxman letter. Drew Armstrong — via his own Twitter account — said Gilead execs had a meeting scheduled with Waxman all along and the letter just seemed like Waxman was making an effort to drag them in. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.37% in … Continue reading Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)

Mark DeFrance
Finance

Bullish Stocks: GTT Communications (NYSEMKT:GTT), MEI Pharma (NASDAQ:MEIP), Inovio Pharmaceuticals Inc. (NYSEMKT:INO), CONN’S (NASDAQ:CONN)

On March 18, 2014, GTT Communications, Inc. (NYSEMKT:GTT) issued a press release relating to the fourth quarter and year ended December 31, 2013 financial results. GTT Communications Inc. (NYSEMKT:GTT) stock performance was 11.86% in last session and finished the day at $10.85. Traded volume was 120,166.00 shares in the last session and the average volume of the stock remained 112,980.00 shares. The beta of the … Continue reading Bullish Stocks: GTT Communications (NYSEMKT:GTT), MEI Pharma (NASDAQ:MEIP), Inovio Pharmaceuticals Inc. (NYSEMKT:INO), CONN’S (NASDAQ:CONN)

Mark DeFrance